Website profile

The Asco Post

ascopost.com
All articles Clear site filter

In the final analysis of the phase III POTOMAC trial reported in The Lancet, De Santis et al found that the addition of durvalumab to bacillus Calmette-Guérin (BCG) induction and maintenance improved disease-free survival in patients with high-risk non–muscle-invasive bladder cancer (NMIBC) who underwent transurethral

  • 19articles · 30d
  • 3+ day agolatest article
  • Aug 18, 2026earliest in window
  • 21%with images
  • 333avg words
articles per day
Covers
People
Places
Organizations
Categories
  • Medical 19
  • Health & Wellness 19
  • Health 16
  • Science & Technology 2
  • Human Interest 1
Site tags
Bylines

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News


ascopost.com > issues > september-10-2026 > long-term-trial-supports-selective-use-of-extended-pelvic-lymph-node-dissection-in-high-grade-prostate-cancer

Long-Term Trial Supports Selective Use of Extended Pelvic Lymph Node Dissection in High-Grade Prostate Cancer

4+ day, 4+ hour ago   (694+ words) By MEG BARBOR, MPH September 10, 2026 Extended pelvic lymph node dissection has long been used during radical prostatectomy to improve staging in men with higher-risk prostate cancer. Whether the more extensive operation also improves cancer outcomes has been less clear. New…...